{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T22:49:29Z","timestamp":1777416569161,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T00:00:00Z","timestamp":1588723200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T00:00:00Z","timestamp":1588723200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81572931"],"award-info":[{"award-number":["81572931"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"crossref","award":["ZYJC18034"],"award-info":[{"award-number":["ZYJC18034"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To explore overall survival (OS) and GISTs-specific survival (GSS) among cancer survivors developing a second primary gastrointestinal stromal tumors (GISTs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a cohort study, where patients with GISTs after another malignancy (AM-GISTs,\n                      <jats:italic>n<\/jats:italic>\n                      = 851) and those with only GISTs (GISTs-1,\n                      <jats:italic>n<\/jats:italic>\n                      = 7660) were identified from the Surveillance, Epidemiology, and End Results registries (1988\u20132016). Clinicopathologic characteristics and survival were compared between the two groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The most commonly diagnosed first primary malignancy was prostate cancer (27.7%), followed by breast cancer (16.2%). OS among AM-GISTs was significantly inferior to that of GISTs-1; 10-year OS was 40.3% vs. 50.0%, (\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001). A contrary finding was observed for GSS (10-year GSS 68.9% vs. 61.8%,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.002). In the AM-GISTs group, a total of 338 patients died, of which 26.0% died of their initial cancer and 40.8% died of GISTs. Independent of demographics and clinicopathological characteristics, mortality from GISTs among AM-GISTs patients was decreased compared with their GISTs-1 counterparts (HR, 0.71; 95% CI, 0.59\u20130.84;\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001), whereas OS was inferior among AM-GISTs (HR, 1.11; 95% CI, 0.99\u20131.25;\n                      <jats:italic>p<\/jats:italic>\n                      = 0.085).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>AM-GISTs patients have decreased risk of dying from GISTs compared with GIST-1. Although another malignancy history does not seemingly affect OS for GISTs patients, clinical treatment of such patients should be cautious.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12957-020-01868-x","type":"journal-article","created":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T11:04:16Z","timestamp":1588763056000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Long-term survival among patients with gastrointestinal stromal tumors diagnosed after another malignancy: a SEER population-based study"],"prefix":"10.1186","volume":"18","author":[{"given":"Chaoyong","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengshi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaolun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaonan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donghao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0254-5843","authenticated-orcid":false,"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zongguang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,6]]},"reference":[{"issue":"2","key":"1868_CR1","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1200\/JCO.2017.74.9705","volume":"36","author":"M von Mehren","year":"2018","unstructured":"von Mehren M, Joensuu H. Gastrointestinal stromal tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2018;36(2):136\u201343.","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology."},{"issue":"8","key":"1868_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020294","volume":"6","author":"F Ducimetiere","year":"2011","unstructured":"Ducimetiere F, Lurkin A, Ranchere-Vince D, Decouvelaere AV, Peoc'h M, Istier L, et al. Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing. PloS one. 2011;6(8):e20294.","journal-title":"PloS one."},{"issue":"2","key":"1868_CR3","volume":"11","author":"N Patel","year":"2019","unstructured":"Patel N, Benipal B. Incidence of gastrointestinal stromal tumors in the United States from 2001-2015: a United States cancer Statistics analysis of 50 states. Cureus. 2019;11(2):e4120.","journal-title":"Cureus."},{"issue":"8","key":"1868_CR4","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/j.ejso.2016.05.022","volume":"42","author":"L Capelli","year":"2016","unstructured":"Capelli L, Petracci E, Quagliuolo V, Saragoni L, Colombo P, Morgagni P, et al. Gastric GISTs: Analysis of c-Kit, PDGFRA and BRAF mutations in relation to prognosis and clinical pathological characteristics of patients - a GIRCG study. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2016;42(8):1206\u201314.","journal-title":"European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology."},{"issue":"1","key":"1868_CR5","first-page":"7","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA: a cancer journal for clinicians. 2019;69(1):7\u201334.","journal-title":"CA: a cancer journal for clinicians."},{"issue":"4","key":"1868_CR6","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S1470-2045(11)70061-4","volume":"12","author":"A Berrington de Gonzalez","year":"2011","unstructured":"Berrington de Gonzalez A, Curtis RE, Kry SF, Gilbert E, Lamart S, Berg CD, et al. Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries. The Lancet Oncology. 2011;12(4):353\u201360.","journal-title":"The Lancet Oncology."},{"issue":"11","key":"1868_CR7","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1634\/theoncologist.2011-0214","volume":"16","author":"AM VanderWalde","year":"2011","unstructured":"VanderWalde AM, Hurria A. Second malignancies among elderly survivors of cancer. The oncologist. 2011;16(11):1572\u201381.","journal-title":"The oncologist."},{"issue":"19","key":"1868_CR8","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1002\/cncr.30164","volume":"122","author":"N Donin","year":"2016","unstructured":"Donin N, Filson C, Drakaki A, Tan HJ, Castillo A, Kwan L, et al. Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008. Cancer. 2016;122(19):3075\u201386.","journal-title":"Cancer."},{"issue":"18","key":"1868_CR9","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1093\/jnci\/dji278","volume":"97","author":"LB Travis","year":"2005","unstructured":"Travis LB, Fossa SD, Schonfeld SJ, McMaster ML, Lynch CF, Storm H, et al. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. Journal of the National Cancer Institute. 2005;97(18):1354\u201365.","journal-title":"Journal of the National Cancer Institute."},{"issue":"34","key":"1868_CR10","doi-asserted-by":"publisher","first-page":"5088","DOI":"10.1200\/JCO.2010.29.5683","volume":"28","author":"MT Milano","year":"2010","unstructured":"Milano MT, Li H, Gail MH, Constine LS, Travis LB. Long-term survival among patients with Hodgkin\u2019s lymphoma who developed breast cancer: a population-based study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010;28(34):5088\u201396.","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology."},{"issue":"24","key":"1868_CR11","doi-asserted-by":"publisher","first-page":"5538","DOI":"10.1002\/cncr.26257","volume":"117","author":"MT Milano","year":"2011","unstructured":"Milano MT, Li H, Constine LS, Travis LB. Survival after second primary lung cancer: a population-based study of 187 Hodgkin lymphoma patients. Cancer. 2011;117(24):5538\u201347.","journal-title":"Cancer."},{"issue":"1","key":"1868_CR12","first-page":"22","volume":"4","author":"MT Milano","year":"2012","unstructured":"Milano MT, Li H, Constine LS, Travis LB. Variables affecting survival after second primary lung cancer: a population-based study of 187 Hodgkin\u2019s lymphoma patients. Journal of thoracic disease. 2012;4(1):22\u20139.","journal-title":"Journal of thoracic disease."},{"issue":"8","key":"1868_CR13","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1097\/JTO.0000000000000213","volume":"9","author":"MT Milano","year":"2014","unstructured":"Milano MT, Strawderman RL, Venigalla S, Ng K, Travis LB. Non-small-cell lung cancer after breast cancer: a population-based study of clinicopathologic characteristics and survival outcomes in 3529 women. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2014;9(8):1081\u201390.","journal-title":"Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer."},{"issue":"5","key":"1868_CR14","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1530\/EJE-13-0309","volume":"169","author":"CH Lu","year":"2013","unstructured":"Lu CH, Lee KD, Chen PT, Chen CC, Kuan FC, Huang CE, et al. Second primary malignancies following thyroid cancer: a population-based study in Taiwan. European journal of endocrinology. 2013;169(5):577\u201385.","journal-title":"European journal of endocrinology."},{"key":"1868_CR15","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.suronc.2019.03.001","volume":"29","author":"F Petrelli","year":"2019","unstructured":"Petrelli F, Tomasello G, Barni S, Varricchio A, Costanzo A, Rampulla V, et al. Risk of second primary tumors in GIST survivors: a systematic review and meta-analysis. Surgical oncology. 2019;29:64\u201370.","journal-title":"Surgical oncology."},{"issue":"2","key":"1868_CR16","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1053\/j.semdp.2006.09.004","volume":"23","author":"A Agaimy","year":"2006","unstructured":"Agaimy A, Wunsch PH, Sobin LH, Lasota J, Miettinen M. Occurrence of other malignancies in patients with gastrointestinal stromal tumors. Seminars in diagnostic pathology. 2006;23(2):120\u20139.","journal-title":"Seminars in diagnostic pathology."},{"issue":"5","key":"1868_CR17","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1093\/annonc\/mdh191","volume":"15","author":"WY Au","year":"2004","unstructured":"Au WY, Ho KM, Shek TW. Papillary renal cell carcinoma and gastrointestinal stromal tumor: a unique association. Annals of oncology : official journal of the European Society for Medical Oncology. 2004;15(5):843\u20134.","journal-title":"Annals of oncology : official journal of the European Society for Medical Oncology."},{"issue":"10","key":"1868_CR18","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1093\/annonc\/mdq078","volume":"21","author":"RK Pandurengan","year":"2010","unstructured":"Pandurengan RK, Dumont AG, Araujo DM, Ludwig JA, Ravi V, Patel S, et al. Survival of patients with multiple primary malignancies: a study of 783 patients with gastrointestinal stromal tumor. Annals of oncology : official journal of the European Society for Medical Oncology. 2010;21(10):2107\u201311.","journal-title":"Annals of oncology : official journal of the European Society for Medical Oncology."},{"issue":"5","key":"1868_CR19","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1093\/annonc\/mdr442","volume":"23","author":"AG Dumont","year":"2012","unstructured":"Dumont AG, Rink L, Godwin AK, Miettinen M, Joensuu H, Strosberg JR, et al. A nonrandom association of gastrointestinal stromal tumor (GIST) and desmoid tumor (deep fibromatosis): case series of 28 patients. Annals of oncology : official journal of the European Society for Medical Oncology. 2012;23(5):1335\u201340.","journal-title":"Annals of oncology : official journal of the European Society for Medical Oncology."},{"issue":"8","key":"1868_CR20","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1245\/s10434-014-4332-z","volume":"22","author":"JF Hechtman","year":"2015","unstructured":"Hechtman JF, DeMatteo R, Nafa K, Chi P, Arcila ME, Dogan S, et al. Additional primary malignancies in patients with gastrointestinal stromal tumor (GIST): a clinicopathologic study of 260 patients with molecular analysis and review of the literature. Annals of surgical oncology. 2015;22(8):2633\u20139.","journal-title":"Annals of surgical oncology."},{"issue":"4","key":"1868_CR21","first-page":"1152","volume":"127","author":"CS Duchateau","year":"2005","unstructured":"Duchateau CS, Stokkel MP. Second primary tumors involving non-small cell lung cancer: prevalence and its influence on survival. Chest. 2005;127(4):1152\u20138.","journal-title":"Chest."},{"issue":"8","key":"1868_CR22","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.medcli.2017.06.010","volume":"149","author":"R Nunez-Martin","year":"2017","unstructured":"Nunez-Martin R, Cubedo Cervera R, Provencio PM. Gastrointestinal stromal tumour and second tumours: a literature review. Medicina clinica. 2017;149(8):345\u201350.","journal-title":"Medicina clinica."},{"issue":"1","key":"1868_CR23","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.molcel.2014.11.021","volume":"57","author":"AV Reshetnyak","year":"2015","unstructured":"Reshetnyak AV, Opatowsky Y, Boggon TJ, Folta-Stogniew E, Tome F, Lax I, et al. The strength and cooperativity of KIT ectodomain contacts determine normal ligand-dependent stimulation or oncogenic activation in cancer. Molecular cell. 2015;57(1):191\u2013201.","journal-title":"Molecular cell."},{"issue":"7","key":"1868_CR24","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1200\/JCO.2012.43.4449","volume":"31","author":"BM Solomon","year":"2013","unstructured":"Solomon BM, Rabe KG, Slager SL, Brewer JD, Cerhan JR, Shanafelt TD. Overall and cancer-specific survival of patients with breast, colon, kidney, and lung cancers with and without chronic lymphocytic leukemia: a SEER population-based study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013;31(7):930\u20137.","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology."},{"issue":"6","key":"1868_CR25","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1002\/cam4.2172","volume":"8","author":"L Deng","year":"2019","unstructured":"Deng L, Harethardottir H, Song H, Xiao Z, Jiang C, Wang Q, et al. Mortality of lung cancer as a second primary malignancy: a population-based cohort study. Cancer medicine. 2019;8(6):3269\u201377.","journal-title":"Cancer medicine."},{"issue":"3","key":"1868_CR26","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S1470-2045(11)70299-6","volume":"13","author":"H Joensuu","year":"2012","unstructured":"Joensuu H, Vehtari A, Riihimaki J, Nishida T, Steigen SE, Brabec P, et al. Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts. The Lancet Oncology. 2012;13(3):265\u201374.","journal-title":"The Lancet Oncology."},{"key":"1868_CR27","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1186\/s12885-015-1554-9","volume":"15","author":"U Guller","year":"2015","unstructured":"Guller U, Tarantino I, Cerny T, Schmied BM, Warschkow R. Population-based SEER trend analysis of overall and cancer-specific survival in 5138 patients with gastrointestinal stromal tumor. BMC cancer. 2015;15:557.","journal-title":"BMC cancer."},{"issue":"1","key":"1868_CR28","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1365-2559.2005.02291.x","volume":"48","author":"BP Rubin","year":"2006","unstructured":"Rubin BP. Gastrointestinal stromal tumours: an update. Histopathology. 2006;48(1):83\u201396.","journal-title":"Histopathology."},{"issue":"109","key":"1868_CR29","first-page":"1224","volume":"58","author":"M Tokunaga","year":"2011","unstructured":"Tokunaga M, Ohyama S, Hiki N, Fukunaga T, Yamamoto N, Yamaguchi T. Incidence and prognostic value of lymph node metastasis on c-Kit-positive gastrointestinal stromal tumors of the stomach. Hepato-gastroenterology. 2011;58(109):1224\u20138.","journal-title":"Hepato-gastroenterology."},{"issue":"5","key":"1868_CR30","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00423-018-1683-0","volume":"403","author":"A Gaitanidis","year":"2018","unstructured":"Gaitanidis A, El Lakis M, Alevizakos M, Tsaroucha A, Pitiakoudis M. Predictors of lymph node metastasis in patients with gastrointestinal stromal tumors (GISTs). Langenbeck's archives of surgery. 2018;403(5):599\u2013606.","journal-title":"Langenbeck's archives of surgery."},{"issue":"10","key":"1868_CR31","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/j.ejso.2018.07.004","volume":"44","author":"W Song","year":"2018","unstructured":"Song W, Lv CG, Miao DL, Zhu ZG, Wu Q, Wang YG, et al. Development and validation of a nomogram for predicting survival in patients with gastrointestinal stromal tumours. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2018;44(10):1657\u201365.","journal-title":"European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology."}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-020-01868-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-020-01868-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-020-01868-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T20:12:39Z","timestamp":1620245559000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-020-01868-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,6]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1868"],"URL":"https:\/\/doi.org\/10.1186\/s12957-020-01868-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.21309\/v1","asserted-by":"object"}]},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,6]]},"assertion":[{"value":"3 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was exempted from Institutional Review Board approval, in view of the SEER\u2019s use of unidentifiable patient information. Due to the strict register-based nature of the study, informed consent was waived.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"88"}}